rituximab
roche,biogen
['ritux', 'imab ']
many hoped rituximab would be the panacea for all with igg4-rd. consistent story: it's not.
in this european data:
- only 56% in remission at 12m
- pancreato-hepato-biliary slightly better, rpf mid-range
this story isn't over. we need other options abst0147 #acr22 
Rheumatologist and clinical pharmacologist, world traveller pretences on the upswing, sometimes podcast host for @austprescriber and others. All opinions my own